Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Galactol® Enzyme Supplement for Post-Prandial Abdominal Bloating in Irritable Bowel Syndrome [NA]

View source ↗

Summary

Clinical trial entry for Galactol Enzyme Supplement in irritable bowel syndrome with abdominal bloating; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galactol Enzyme Supplement

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Irritable Bowel Syndrome, Abdominal Bloating | NA | Status: NOT_YET_RECRUITING